Raymond James & Associates Insulet Corp Call Options Transaction History
Raymond James & Associates
- $150 Billion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding PODD
# of Institutions
659Shares Held
63.5MCall Options Held
385KPut Options Held
773K-
Vanguard Group Inc Valley Forge, PA8.4MShares$1.98 Billion0.03% of portfolio
-
Capital Research Global Investors Los Angeles, CA7.15MShares$1.68 Billion0.33% of portfolio
-
Black Rock Inc. New York, NY6.06MShares$1.43 Billion0.03% of portfolio
-
State Street Corp Boston, MA2.86MShares$673 Million0.03% of portfolio
-
Baillie Gifford & CO1.89MShares$444 Million0.3% of portfolio
About INSULET CORP
- Ticker PODD
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 69,403,600
- Market Cap $16.3B
- Description
- Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sel...